Risk factors for the development of postoperative complications in patients with metastatic kidney cancer treated with cytoreductive nephrectomy

被引:0
作者
Hernandez-Paneda, Humberto [1 ]
Garza-Gangemi, Adrian M. [1 ]
Manzanilla-Romero, Hector H. [1 ]
Hernandez-Gaytan, Cristian A. [1 ]
Gabilondo-Navarro, Fernando [1 ]
Rodriguez-Covarrubias, Francisco [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Urol, Ciudad De Mexico, Mexico
来源
CIRUGIA Y CIRUJANOS | 2021年 / 89卷 / 05期
关键词
Cytoreduction surgical procedures; Nephrectomy; Postoperative complications; SURGICAL COMPLICATIONS; SURVIVAL;
D O I
10.24875/CIRU.20000871
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The role of cytoreductive nephrectomy on the treatment of metastatic renal cell carcinoma (mRCC) is controversial due to its high complexity. Objective: To identify risk factors associated to postoperative complications in patients with mRCC after cytoreductive nephrectomy. Method: We conducted a retrospective, observational study in 67 patients who underwent cytoreductive nephrectomy for the management of mRCC. Demographic, perioperative and clinicopathologic -characteristics were registered. Surgical complications were classified using the Clavien-Dindo system; major complications were those of grade 3 or higher. We performed a binary logistic regression analysis to identify risk factors associated with surgical complications. Results: Mean age was 56 years (37-83). Symptoms were present in 58 patients (89.7%). Weight loss was the predominant symptom (50.8%). Mean tumor diameter was 10.8 cm (4.6-22.5 cm). The rate of postoperative complications was 65%; 21 patients (31.4%) had major complications. Risk factors were estimated blood loss > 500 ml (OR 44.5, CI 95% 2.51-789, p = 0.01) and tumor diameter > 10 cm (OR 17.9, CI 95% 1.2-273, p = 0.04). Conclusions: Cytoreductive nephrectomy is a good option in highly selected patients with mRCC. Our major complication rate was 31.4%. Risk factors associated were blood loss and tumor diameter.
引用
收藏
页码:632 / 637
页数:6
相关论文
共 27 条
[1]  
Abouleish A.E., 2015, ASA Newsletter, V79, P38
[2]   Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The SURTIME Randomized Clinical Trial [J].
Bex, Axel ;
Mulders, Peter ;
Jewett, Michael ;
Wagstaff, John ;
van Thienen, Johannes V. ;
Blank, Christian U. ;
van Velthoven, Roland ;
Laguna, Maria del Pilar ;
Wood, Lori ;
van Melick, Harm H. E. ;
Aarts, Maureen J. ;
Lattouf, J. B. ;
Powles, Thomas ;
de Jong, Igle Jan ;
Rottey, Sylvie ;
Tombal, Bertrand ;
Marreaud, Sandrine ;
Collette, Sandra ;
Collette, Laurence ;
Haanen, John .
JAMA ONCOLOGY, 2019, 5 (02) :164-170
[3]  
Bhindi B, 2019, EUR UROL, V75, P111, DOI [10.1016/j.eururo.2018.09.016, 10.1016/j.eururo.2018.11.021]
[4]   Laparoscopic Cytoreductive Nephrectomy: A Three-Center Retrospective Analysis [J].
Blick, Christopher ;
Bott, Simon ;
Muneer, Asif ;
Barber, Neil J. ;
Hindley, Richard ;
Eden, Christopher ;
Sullivan, Mark .
JOURNAL OF ENDOUROLOGY, 2010, 24 (09) :1451-1455
[5]   Epidemiology of Renal Cell Carcinoma [J].
Capitanio, Umberto ;
Bensalah, Karim ;
Bex, Axel ;
Boorjian, Stephen A. ;
Bray, Freddie ;
Coleman, Jonathan ;
Gore, John L. ;
Sun, Maxine ;
Wood, Christopher ;
Russo, Paul .
EUROPEAN UROLOGY, 2019, 75 (01) :74-84
[6]  
Castellano-Orozco M, 2008, REV MEX UROL, V68, P207
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era [J].
Conti, Simon L. ;
Thomas, I-Chun ;
Hagedorn, Judith C. ;
Chung, Benjamin I. ;
Chertow, Glenn M. ;
Wagner, Todd H. ;
Brooks, James D. ;
Srinivas, Sandy ;
Leppert, John T. .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) :2245-2252
[9]  
Cruz-Ruiz J, 2019, GAC MEX ONCOL, V18, P48
[10]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213